Erratum. Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived? Diabetes Care 2017;40:813–820

نویسندگان

  • Muhammad Abdul-Ghani
  • Ralph A. DeFronzo
  • Stefano Del Prato
  • Robert Chilton
  • Rajvir Singh
  • Robert E.J. Ryder
چکیده

In the article listed above, the sentence on page 814 that reads “There also were more serious hypoglycemic events in the liraglutide arm and more sulfonylurea and insulin use in the placebo group” has been corrected to read “There was more sulfonylurea and insulin use in the placebo group.” The online version has been corrected to reflect this change. Muhammad Abdul-Ghani, Ralph A. DeFronzo, Stefano Del Prato, Robert Chilton, Rajvir Singh, and Robert E.J. Ryder Diabetes Care 1

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived?

Hyperglycemia is the major risk factor for microvascular complications in patients with type 2 diabetes (T2D). However, cardiovascular disease (CVD) is the principal cause of death, and lowering HbA1c has only a modest effect on reducing CVD risk and mortality. The recently published LEADER and SUSTAIN-6 trials demonstrate that, in T2D patients with high CVD risk, the glucagon-like peptide 1 re...

متن کامل

Erratum. Mitigating Cardiovascular Risk in Type 2 Diabetes With Antidiabetes Drugs: A Review of Principal Cardiovascular Outcome Results of EMPA-REG OUTCOME, LEADER, and SUSTAIN-6 Trials. Diabetes Care 2017;40:821–831

In the article cited above, there are typographical errors in Table 3 with regard to the values for hospitalization for heart failure results. The results should state an incidence of 2.7% (126/4,687) with empagliflozin and 4.1% (95/2,333) with placebo, and the corresponding incidence rates should be 9.4/1,000 patient-years and 14.5/1,000 patient-years, respectively. The HR of 0.65 (95% CI 0.50...

متن کامل

EVALUATION OF METABOLIC PROFILE OF PLASMA AMINO ACIDS IN DIABETIC PATIENTS WITH CARDIOVASCULAR DISEASES

Background: Diabetes mellitus is one of the most common endocrine diseases. Cardiovascular disease (CVD) is one of the leading causes of death in patients with type 2 diabetes. The aim of this study was to investigate the metabolic profile of plasma amino acids in diabetic patients with cardiovascular disease. Methods: The present study is a descriptive-analytical cross-sectional study on 140 ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 40  شماره 

صفحات  -

تاریخ انتشار 2017